Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study. by Rebecca Berhanu, Kathryn Schnippel, Erika Mohr, Kamban Hirasen, Denise Evans, Sydney Rosen, Ian Sanne

Get full text

“This is not my body”: Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis by Marian Loveday, Sindisiwe Hlangu, Lee-Megan Larkan, Helen Cox, Johnny Daniels, Erika Mohr-Holland, Jennifer Furin

Get full text

"This is not my body": Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis. by Marian Loveday, Sindisiwe Hlangu, Lee-Megan Larkan, Helen Cox, Johnny Daniels, Erika Mohr-Holland, Jennifer Furin

Get full text

"Life continues": Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa. by Erika Mohr, Leigh Snyman, Zodwa Mbakaz, Judy Caldwell, Virginia DeAzevedo, Yulene Kock, Laura Trivino Duran, Emilie Venables

Get full text

Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa by Erika Mohr-Holland, Anja Reuter, Jennifer Furin, Anthony Garcia-Prats, Virginia De Azevedo, Vanessa Mudaly, Yulene Kock, Laura Trivino-Duran, Petros Isaakidis, Jennifer Hughes

Get full text

Six-Month Response to Delamanid Treatment in MDR TB Patients by Cathy Hewison, Gabriella Ferlazzo, Zaza Avaliani, Armen Hayrapetyan, Sylvie Jonckheere, Zarema Khaidarkhanova, Erika Mohr, Animesh Sinha, Alena Skrahina, Debrah Vambe, Irina Vasilyeva, Nathalie Lachenal, Francis Varaine

Get full text

Implementing a Substance-Use Screening and Intervention Program for People Living with Rifampicin-Resistant Tuberculosis: Pragmatic Experience from Khayelitsha, South Africa by Anja Reuter, Buci Beko, Boniwe Memani, Jennifer Furin, Johnny Daniels, Erickmar Rodriguez, Hermann Reuter, Lize Weich, Petros Isaakidis, Erin von der Heyden, Yulene Kock, Erika Mohr-Holland

Get full text

DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting. by Erika Mohr, Johnny Daniels, Busisiwe Beko, Petros Isaakidis, Vivian Cox, Sarah Jane Steele, Odelia Muller, Leigh Snyman, Virginia De Azevedo, Amir Shroufi, Laura Trivino Duran, Jennifer Hughes

Get full text

Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success. by Johnny Flippie Daniels, Mohammed Khogali, Erika Mohr, Vivian Cox, Sizulu Moyo, Mary Edginton, Sven Gudmund Hinderaker, Graeme Meintjes, Jennifer Hughes, Virginia De Azevedo, Gilles van Cutsem, Helen Suzanne Cox

Get full text

Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa... by Helen Cox, ProfPhD, Zubeida Salaam-Dreyer, PhD, Galo A Goig, PhD, Mark P Nicol, ProfPhD, Fabrizio Menardo, PhD, Anzaan Dippenaar, PhD, Erika Mohr-Holland, MPH, Johnny Daniels, BA, Patrick G T Cudahy, PhD, Sonia Borrell, PhD, Miriam Reinhard, MD, Anna Doetsch, MSc, Christian Beisel, PhD, Anja Reuter, MD, Jennifer Furin, MD, Sebastien Gagneux, ProfPhD, Robin M Warren, ProfPhD

Get full text